抗药多种生物:烧伤患者的沉默困境
Randa Elsheikh1, Abdelrahman M Makram2
1Deanery of Biomedical Sciences at Edinburgh Medical School, University of Edinburgh, Edinburgh EH8 9YL, UK.
概括
耐多药生物体 (MDROs) 构成重大威胁,特别是在免疫力低下的患者中燃烧. 本综述侧重于MDROs在烧伤护理,讨论治疗方法,并强调抗生素管理.
科学领域:
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
- 燃烧管理 燃烧管理
背景情况:
- 全球多耐药生物体 (MDROs) 的全球上升对全球医疗保健系统构成了关键挑战.
- 烧伤患者特别容易受到严重感染,因为他们的超代谢状态和免疫障碍受到损害.
- 这些患者面临的风险与长时间住院患者相似,包括呼吸机相关的肺炎和尿路感染.
研究的目的:
- 审查当前关于感染中多药耐药性的知识.
- 特别关注MDRO在烧伤患者中所带来的挑战.
- 讨论致病生物,治疗策略,以及抗生素管理的重要性.
主要方法:
- 关于多药耐药性的当前研究的文献综述.
- 对烧伤患者的感染风险和致病生物的分析.
- 讨论既有和新兴的治疗选择和预防策略.
主要成果:
- 烧伤患者由于免疫力受损和高代谢症而面临高感染风险.
- 常见的在医院获得的感染,如VAP和尿路感染,在这个人群中被MDRO加剧.
- 讨论了管理策略的共识,突出了协议领域和正在进行的辩论.
结论:
- 在烧伤患者中有效管理MDROs需要多学科的方法.
- 抗生素管理计划对于打击耐药性传播至关重要.
- 团队合作和遵守最佳实践对于控制脆弱患者群体的MDRO爆发至关重要.
相关概念视频
Burn Injuries
2.5K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.5K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pulmonary Tuberculosis V
178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
Pulmonary Tuberculosis I
241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323


